Amber Giles
Impact in
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 7
- Cancer Cells and Metastasis 7
- Immunology 13
- Immune cells in cancer 10
- Immune Cell Function and Interaction 3
- T-cell and B-cell Immunology 2
- Co-authors
- Mark R. Gilbert (14 shared papers)Rosandra N. Kaplan (7 shared papers)Crystal L. Mackall (2 shared papers)Steven L. Highfill (4 shared papers)Hua Zhang (1 shared paper)Jillian Smith (1 shared paper)Yongzhi Cui (1 shared paper)Elizabeth M. Morse (1 shared paper)
- Journals
- Neuro-Oncology (5 papers)Cancer Research (5 papers)Journal for ImmunoTherapy of Cancer (3 papers)Oncotarget (2 papers)The FASEB Journal (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Amber Giles
26 papers receiving 2.1k citations
Amber Giles's Hit Papers
Peers
Comparison fields: 5 of 106
- Geriatrics and Gerontology 166
- Immunology 759
- Oncology 744
- Genetics 261
- Cancer Research 217
Countries citing papers authored by Amber Giles
This map shows the geographic impact of Amber Giles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber Giles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber Giles more than expected).
Fields of papers citing papers by Amber Giles
This network shows the impact of papers produced by Amber Giles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber Giles. The network helps show where Amber Giles may publish in the future.
Co-authors
The 25 scholars most cited alongside Amber Giles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy Hit paper breakdown → | 2014 | 609 |
| 2 | Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy Hit paper breakdown → | 2018 | 346 |
| 3 | 2011 | 251 | |
| 4 | 2013 | 241 | |
| 5 | 2016 | 201 | |
| 6 | 2016 | 118 | |
| 7 | 2018 | 84 | |
| 8 | 2019 | 73 | |
| 9 | 2020 | 35 | |
| 10 | 2017 | 33 | |
| 11 | 2018 | 30 | |
| 12 | 2018 | 25 | |
| 13 | 2017 | 25 | |
| 14 | 2017 | 22 | |
| 15 | 2021 | 21 | |
| 16 | 2015 | 16 | |
| 17 | 2016 | 14 | |
| 18 | 2020 | 7 | |
| 19 | 2009 | 6 | |
| 20 | 2015 | 4 |
About Amber Giles
Amber Giles is a scholar working on Oncology, Immunology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 2.2k indexed citations. Recurring topics across this work include Immune cells in cancer (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer Cells and Metastasis (7 papers), Glioma Diagnosis and Treatment (6 papers), Immune Cell Function and Interaction (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), T-cell and B-cell Immunology (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Geriatrics and Gerontology (166 citations), Immunology (759 citations), Oncology (744 citations), Genetics (261 citations) and Cancer Research (217 citations). Amber Giles has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Mark R. Gilbert, Rosandra N. Kaplan, Crystal L. Mackall, Steven L. Highfill, Hua Zhang, Jillian Smith, Yongzhi Cui, Elizabeth M. Morse, Deric M. Park and Nivedita M. Ratnam. Their work appears in journals such as Neuro-Oncology, Cancer Research, Journal for ImmunoTherapy of Cancer, Oncotarget and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.